<?xml version="1.0" encoding="UTF-8"?>
<p>The VEEV TC-83 strain is the only licensed live-attenuated vaccine available to protect horses in endemic regions. This vaccine strain has been developed by passaging the Trinidad donkey (TrD) IA/B strains 83 times in guinea pig heart cells [
 <xref ref-type="bibr" rid="B112">112</xref>]. Genetic characterization of the TC-83 strain indicates that the attenuation phenotype relies on only two point mutations (nucleotide position 3 in 5'-noncoding region and amino acid position 120 in E2 glycoprotein) [
 <xref ref-type="bibr" rid="B113">113</xref>,
 <xref ref-type="bibr" rid="B114">114</xref>]. Currently, there is no licensed human VEEV vaccine, but TC-83 live-attenuated vaccine is used for laboratory workers and military personnel [
 <xref ref-type="bibr" rid="B115">115</xref>].
</p>
